Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Exploration of Targeted Anti-Tumor Therapy
|
November 7, 2022
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
Daniela Criscuolo, Francesco Morra, Angela Celetti
Journal of Experimental & Clinical Cancer Research : CR
|
November 26, 2016
Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic
Aniello Cerrato, Francesco Morra, Angela Celetti
International Journal of Cancer
|
October 19, 2017
CCDC6: the identity of a protein known to be partner in fusion
Aniello Cerrato, Francesco Merolla, Francesco Morra, et al.
International Journal of Molecular Sciences
|
June 28, 2017
The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy
Roberta Visconti, Francesco Morra, Gianluca Guggino, et al.
Cancers
|
December 28, 2019
NSCLC Mutated Isoforms of CCDC6 Affect the Intracellular Distribution of the Wild Type Protein Promoting Cisplatinum Resistance and PARP Inhibitors Sensitivity in Lung Cancer Cells
Aniello Cerrato, Francesco Morra, Imma Di Domenico, et al.
Respiratory Physiology & Neurobiology
|
July 6, 2013
The effect of body cooling on respiratory system mechanics and hysteresis in rats
Alessandro Rubini, Dania El-Mazloum, Francesco Morra, et al.
International Journal of Molecular Sciences
|
June 28, 2019
Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 23, 2019
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, et al.
Cancers
|
February 13, 2021
Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer
Federica Liotti, Maria Marotta, Daniela Sorriento, et al.
Heliyon
|
November 29, 2021
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis
Francesco Morra, Francesco Merolla, Federica Zito Marino, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Exploration of Targeted Anti-Tumor Therapy
|
November 7, 2022
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
Daniela Criscuolo, Francesco Morra, Angela Celetti
Journal of Experimental & Clinical Cancer Research : CR
|
November 26, 2016
Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic
Aniello Cerrato, Francesco Morra, Angela Celetti
International Journal of Cancer
|
October 19, 2017
CCDC6: the identity of a protein known to be partner in fusion
Aniello Cerrato, Francesco Merolla, Francesco Morra, et al.
International Journal of Molecular Sciences
|
June 28, 2017
The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy
Roberta Visconti, Francesco Morra, Gianluca Guggino, et al.
Cancers
|
December 28, 2019
NSCLC Mutated Isoforms of CCDC6 Affect the Intracellular Distribution of the Wild Type Protein Promoting Cisplatinum Resistance and PARP Inhibitors Sensitivity in Lung Cancer Cells
Aniello Cerrato, Francesco Morra, Imma Di Domenico, et al.
Respiratory Physiology & Neurobiology
|
July 6, 2013
The effect of body cooling on respiratory system mechanics and hysteresis in rats
Alessandro Rubini, Dania El-Mazloum, Francesco Morra, et al.
International Journal of Molecular Sciences
|
June 28, 2019
Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 23, 2019
New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, et al.
Cancers
|
February 13, 2021
Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer
Federica Liotti, Maria Marotta, Daniela Sorriento, et al.
Heliyon
|
November 29, 2021
The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis
Francesco Morra, Francesco Merolla, Federica Zito Marino, et al.
Page
of 3